Cargando…

Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study

BACKGROUND: Long non-coding RNAs are RNAs longer than 200 bps that do not encode any proteins and are able to alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. They represent a class of biomarkers of crescent interest in the hematolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Buono, Lorena, Iside, Concetta, De Matteo, Antonia, Stellato, Pio, Beneduce, Giuliana, de Vera d’Aragona, Roberta Penta, Parasole, Rosanna, Salvatore, Marco, Smaldone, Giovanni, Mirabelli, Peppino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710039/
https://www.ncbi.nlm.nih.gov/pubmed/36451206
http://dx.doi.org/10.1186/s12935-022-02789-3
_version_ 1784841286785695744
author Buono, Lorena
Iside, Concetta
De Matteo, Antonia
Stellato, Pio
Beneduce, Giuliana
de Vera d’Aragona, Roberta Penta
Parasole, Rosanna
Salvatore, Marco
Smaldone, Giovanni
Mirabelli, Peppino
author_facet Buono, Lorena
Iside, Concetta
De Matteo, Antonia
Stellato, Pio
Beneduce, Giuliana
de Vera d’Aragona, Roberta Penta
Parasole, Rosanna
Salvatore, Marco
Smaldone, Giovanni
Mirabelli, Peppino
author_sort Buono, Lorena
collection PubMed
description BACKGROUND: Long non-coding RNAs are RNAs longer than 200 bps that do not encode any proteins and are able to alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. They represent a class of biomarkers of crescent interest in the hematologic and oncologic fields. Recent studies showed that the expression levels of specific lncRNAs correlate with the prognosis of paediatric patients with Acute Lymphoblastic Leukaemia. METHODS: We used NGS approaches to analyse the transcriptome of 9 childhood B-ALL patients and 6 childhood T-ALL patients, in comparison with B and T healthy lymphocytes from cord blood. We validate our findings both ex vivo, in a different cohort of 10 B-ALL and 10 T-ALL patients, and in silico using public datasets. RESULTS: We characterised the lncRNA landscape for B-ALL, T-ALL, healthy B, and T cell progenitors. From the characterised signature, we selected candidate lncRNAs able to discriminate not only B-ALL and T-ALL from healthy subjects but also between the two types of leukaemia, and subsequently validated their potential as a diagnostic tool in an additional cohort of paediatric patients. We confirmed our finding with open access transcriptomic data, comparing ALL lncRNAs with AML lncRNA landscape as well. Finally, expression correlation analyses of T-ALL selected lncRNA biomarkers suggested a possible role in lymphocyte activation and the β-catenin signalling pathway for AC247036.1 and involvement in hedgehog signalling for HHIP-AS1. CONCLUSIONS: Our work identified a lncRNA signature discriminating paediatric B-ALL and T-ALL from healthy subjects, between them and from AML. This study provides the keystone to future clinical studies determining the theragnostic value of the characterised long non coding transcriptome panorama in a clinical setting for childhood patient management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02789-3.
format Online
Article
Text
id pubmed-9710039
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97100392022-12-01 Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study Buono, Lorena Iside, Concetta De Matteo, Antonia Stellato, Pio Beneduce, Giuliana de Vera d’Aragona, Roberta Penta Parasole, Rosanna Salvatore, Marco Smaldone, Giovanni Mirabelli, Peppino Cancer Cell Int Research BACKGROUND: Long non-coding RNAs are RNAs longer than 200 bps that do not encode any proteins and are able to alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. They represent a class of biomarkers of crescent interest in the hematologic and oncologic fields. Recent studies showed that the expression levels of specific lncRNAs correlate with the prognosis of paediatric patients with Acute Lymphoblastic Leukaemia. METHODS: We used NGS approaches to analyse the transcriptome of 9 childhood B-ALL patients and 6 childhood T-ALL patients, in comparison with B and T healthy lymphocytes from cord blood. We validate our findings both ex vivo, in a different cohort of 10 B-ALL and 10 T-ALL patients, and in silico using public datasets. RESULTS: We characterised the lncRNA landscape for B-ALL, T-ALL, healthy B, and T cell progenitors. From the characterised signature, we selected candidate lncRNAs able to discriminate not only B-ALL and T-ALL from healthy subjects but also between the two types of leukaemia, and subsequently validated their potential as a diagnostic tool in an additional cohort of paediatric patients. We confirmed our finding with open access transcriptomic data, comparing ALL lncRNAs with AML lncRNA landscape as well. Finally, expression correlation analyses of T-ALL selected lncRNA biomarkers suggested a possible role in lymphocyte activation and the β-catenin signalling pathway for AC247036.1 and involvement in hedgehog signalling for HHIP-AS1. CONCLUSIONS: Our work identified a lncRNA signature discriminating paediatric B-ALL and T-ALL from healthy subjects, between them and from AML. This study provides the keystone to future clinical studies determining the theragnostic value of the characterised long non coding transcriptome panorama in a clinical setting for childhood patient management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02789-3. BioMed Central 2022-11-30 /pmc/articles/PMC9710039/ /pubmed/36451206 http://dx.doi.org/10.1186/s12935-022-02789-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Buono, Lorena
Iside, Concetta
De Matteo, Antonia
Stellato, Pio
Beneduce, Giuliana
de Vera d’Aragona, Roberta Penta
Parasole, Rosanna
Salvatore, Marco
Smaldone, Giovanni
Mirabelli, Peppino
Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study
title Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study
title_full Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study
title_fullStr Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study
title_full_unstemmed Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study
title_short Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study
title_sort specific lncrna signatures discriminate childhood acute leukaemias: a pilot study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710039/
https://www.ncbi.nlm.nih.gov/pubmed/36451206
http://dx.doi.org/10.1186/s12935-022-02789-3
work_keys_str_mv AT buonolorena specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT isideconcetta specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT dematteoantonia specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT stellatopio specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT beneducegiuliana specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT deveradaragonarobertapenta specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT parasolerosanna specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT salvatoremarco specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT smaldonegiovanni specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy
AT mirabellipeppino specificlncrnasignaturesdiscriminatechildhoodacuteleukaemiasapilotstudy